Project Lead: Dr John Cafferkey

Procalcitonin is a marker of bacterial infection which can be measured in the blood. It is a relatively new test which is already used in some hospitals, mostly to help doctors understand what is causing severe infections.

We used this test during the COVID-19 pandemic because some data suggested it shows how unwell someone might become in the early stages of COVID-19. It could also be useful to identify patients who have bacterial infections on top of the COVID-19 disease or give doctors a measure of whether the disease is becoming more severe.

We want to find out whether this test was accurate, and whether it added important information beyond some of the more commonplace tests we do in the hospital. Understanding this will help us decide whether we should carry on doing the test in the future.

Other Projects

placeholder

Regular reports on COVID-19 cases admitted to NHSL secondary care to support regional research strategy Professor Tim Walsh Covid-19 Project

The COVID-19 pandemic requires an urgent effort to both understand the disease and its impact on people, and also research to rapidly find effective treat...
Read More
placeholder

Utilisation and value of procalcitonin testing in NHS Lothian patients during the COVID-19 pandemic Dr Sara Jenks Covid-19 Project

Procalciton in is a marker of bacterial infection which can be measured in the blood. Data has shown it is able to be used as a prognostic marker in COVID...
Read More